We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    CYC682 – 12
Previous Study | Return to List | Next Study

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (SEAMLESS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01303796
Recruitment Status : Unknown
Verified September 2012 by Cyclacel Pharmaceuticals, Inc..
Recruitment status was:  Active, not recruiting
First Posted : February 25, 2011
Last Update Posted : August 19, 2015
Sponsor:
Information provided by (Responsible Party):
Cyclacel Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2015
  Estimated Study Completion Date : November 2015